Formulations pharmaceutiques contenant un hydrate de propylèneglycol dapagliflozine

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

申请号：

EP12153939.9

公开号：

EP2508188A1

申请日:

2008.03.21

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include dapagliflozin propylene glycol hydrate is: Formula (Ia) or Formula (Ib) and a pharmaceutical acceptable carrier therefore, which formulation is designed for immediate release. The formulations are used for the treatment of diabetes and related diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/